SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-190025
Filing Date
2021-06-14
Accepted
2021-06-14 16:07:59
Documents
3
Period of Report
2021-06-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d175301d8k.htm 8-K 18234
2 EX-99.1 d175301dex991.htm EX-99.1 41280
3 GRAPHIC g175301logo.jpg GRAPHIC 3366
  Complete submission text file 0001193125-21-190025.txt   65431
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 211014690
SIC: 2836 Biological Products, (No Diagnostic Substances)